Furthermore, IWP-2 significantly reduced the cancer stem cell population in tamoxifen resistant cells, as confirmed by reduced capacity for mammosphere formation (Fig 7E) and a reduction in the percentage of CD44+CD24−/low cells (Fig 7F). This evidence concerns the gene CD44 and cancer.